Top Markets
#1 Black Phoenix Black Phoenix +365.41%
#2 Islamic Coin Islamic Coin +158.20%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.15%
#5 Akedo Akedo +35.88%
#6 Acurast Acurast +29.21%
#7 BasedHype BasedHype +27.99%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.11%
#9 Cryptopia Cryptopia +21.42%
#10 GoPlus Security GoPlus Security +20.47%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Rangering i aksjer #41146
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Aksjekurs
$0.04082105
Sist synkronisert: 2024-08-12
Markedsverdi
$39.09K
Endring (1 dag)
-19.83%
Endring (1 år)
0.00%
Land
GB
Handel Destiny Pharma plc (DEST)

Kategori

Healthcare
Driftsmargin for Destiny Pharma plc (DEST)
Driftsmargin per August 2026 TTM: -790.08%
Ifølge Destiny Pharma plc sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) -790.08%. Ved slutten av 2022 hadde selskapet en driftsmargin på -5,104.35%.
Historikk for driftsmargin for Destiny Pharma plc fra 2013 til 2026
Driftsmargin ved slutten av hvert år
År Driftsmargin Endre
2026 (TTM) -790.08% 0.00%
2023 -790.08% -84.52%
2022 -5,104.35% 7.13%
2021 -4,764.75% -90.95%
2020 -52,638.31% 2,654.95%
2019 -1,910.68% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
Driftsmargin for lignende selskaper eller konkurrenter
Selskap Driftsmargin Forskjell i driftsmargin Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -100.05%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.04%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -100.04%
BE
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.